Who has invested in Phanes Therapeutics?

Sequoia Capital China are named among the investors backing Phanes Therapeutics.

Phanes Therapeutics Funding: $40M Raised, Series B (2021)

Phanes Therapeutics funding overview

Phanes Therapeutics is based in San Diego, California. Phanes Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Phanes Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Sequoia Capital China.

Phanes Therapeutics at a glance

Total raised: $40M
Latest round: Series B
Latest round date: May 2021
Headquarters: San Diego, California
Notable investors: Sequoia Capital China

Frequently asked about Phanes Therapeutics funding

How much has Phanes Therapeutics raised?: Phanes Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Phanes Therapeutics?: Sequoia Capital China are named among the investors backing Phanes Therapeutics.
What was the latest Phanes Therapeutics funding round?: The most recent disclosed round is a Series B, announced in May 2021.
Where is Phanes Therapeutics based?: Phanes Therapeutics is based in San Diego, California.
When did Phanes Therapeutics last raise?: The last disclosed Phanes Therapeutics round closed in May 2021 at Series B.

Phanes Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Phanes Therapeutics Funding: $40M Raised, Series B (2021)

Phanes Therapeutics funding overview

Phanes Therapeutics at a glance

Frequently asked about Phanes Therapeutics funding

Companies related to Phanes Therapeutics (36)

Browse related funding lists (6)